Overview

Effect of Celecoxib on Markers of Vascular Inflammation

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This study involves a drug called celecoxib, which is commonly prescribed for people with arthritis. Arthritis is caused by inflammation of the joints or tissues. Inflammation also occurs in the blood vessels that lead to your heart, and the purpose of this study is to see if celecoxib can reduce the blood vessel inflammation associated with high cholesterol and heart disease.
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Collaborator:
Pfizer
Treatments:
Celecoxib